Shopping Cart
- Remove All
- Your shopping cart is currently empty
ST3932 is a ST1535 metabolite, is a adenosine A2A receptor antagonist(Kis of 8 nM and 33 nM for A2A and A1 receptors, respectively).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,670 | 6-8 weeks | |
50 mg | $2,180 | 6-8 weeks | |
100 mg | $2,800 | 6-8 weeks |
Description | ST3932 is a ST1535 metabolite, is a adenosine A2A receptor antagonist(Kis of 8 nM and 33 nM for A2A and A1 receptors, respectively). |
Targets&IC50 | A2A receptor:ki: 8 nM , A1 receptor:33 nM (ki) |
In vitro | ST3932 is a ST1535 metabolite, acts as an adenosine A2A receptor antagonist(Kis of 8 nM and 33 nM for A2A and A1 receptors, respectively). ST3932 inhibits agonist-induced cAMP accumulation(IC50 : 450 nM). |
In vivo | In mice, Haloperidol-induced catalepsy antagonized by ST3932 (10, 20, 40 mg/kg, p.o.), and increases motor activity . ST3932 (20, 40 mg/kg, i.p.) significantly increases the number of contralateral turns induced by l-DOPA in rats. |
Molecular Weight | 288.31 |
Formula | C12H16N8O |
Cas No. | 1246018-21-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.